Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice.
Syed F, Ballew O, Lee CC, Rana J, Krishnan P, Castela A, Weaver SA, Chalasani NS, Thomaidou SF, Demine S, Chang G, Coomans de Brachène A, Alvelos MI, Marselli L, Orr K, Felton JL, Liu J, Marchetti P, Zaldumbide A, Scheuner D, Eizirik DL, Evans-Molina C.
Syed F, et al. Among authors: lee cc.
bioRxiv [Preprint]. 2024 May 9:2024.03.20.585925. doi: 10.1101/2024.03.20.585925.
bioRxiv. 2024.
PMID: 38766166
Free PMC article.
Preprint.